Andrographolide ameliorates hepatic steatosis by suppressing FATP2-mediated fatty acid uptake in mice with nonalcoholic fatty liver disease

[1]  Qiang Xu,et al.  Advances in ameliorating inflammatory diseases and cancers by andrographolide: Pharmacokinetics, pharmacodynamics, and perspective , 2021, Medicinal research reviews.

[2]  H. El‐Serag,et al.  Global epidemiology of NAFLD-related HCC: trends, predictions, risk factors and prevention , 2020, Nature Reviews Gastroenterology & Hepatology.

[3]  G. Kumar,et al.  Andrographolide: Chemical modification and its effect on biological activities. , 2019, Bioorganic chemistry.

[4]  T. Kellogg,et al.  Evolution of NAFLD and Its Management. , 2019, Nutrition in clinical practice : official publication of the American Society for Parenteral and Enteral Nutrition.

[5]  Jian Sun,et al.  Inhibition of AIM2 inflammasome-mediated pyroptosis by Andrographolide contributes to amelioration of radiation-induced lung inflammation and fibrosis , 2019, Cell Death & Disease.

[6]  J. Lykkesfeldt,et al.  Molecular mechanisms of hepatic lipid accumulation in non-alcoholic fatty liver disease , 2018, Cellular and Molecular Life Sciences.

[7]  N. Al-Dhabi,et al.  Effect of two andrographolide derivatives on cellular and rodent models of non-alcoholic fatty liver disease. , 2017, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

[8]  K. Kuo,et al.  Pioglitazone Enhances Cytosolic Lipolysis, β-oxidation and Autophagy to Ameliorate Hepatic Steatosis , 2017, Scientific Reports.

[9]  A. Wree,et al.  Andrographolide Ameliorates Inflammation and Fibrogenesis and Attenuates Inflammasome Activation in Experimental Non-Alcoholic Steatohepatitis , 2017, Scientific Reports.

[10]  Qiang Xu,et al.  Andrographolide sulfonate ameliorates lipopolysaccharide-induced acute lung injury in mice by down-regulating MAPK and NF-κB pathways , 2016, Acta pharmaceutica Sinica. B.

[11]  J. Fitzgerald,et al.  Gout Guidelines: The Good, the Bad, and the Future , 2014 .

[12]  Li Yang,et al.  Andrographolide Prevents High-Fat Diet–Induced Obesity in C57BL/6 Mice by Suppressing the Sterol Regulatory Element-Binding Protein Pathway , 2014, The Journal of Pharmacology and Experimental Therapeutics.

[13]  S. Koo,et al.  Nonalcoholic fatty liver disease: molecular mechanisms for the hepatic steatosis , 2013, Clinical and molecular hepatology.

[14]  M. Mandal,et al.  Evaluation of anti-bacterial and anti-oxidant potential of andrographolide and echiodinin isolated from callus culture of Andrographis paniculata Nees. , 2013, Asian Pacific journal of tropical biomedicine.

[15]  J. M. Suh,et al.  PPARγ signaling and metabolism: the good, the bad and the future , 2013, Nature Medicine.

[16]  D. Xia,et al.  Andrographolide sensitizes cisplatin-induced apoptosis via suppression of autophagosome-lysosome fusion in human cancer cells , 2012, Autophagy.

[17]  L. Gordon,et al.  Mitochondrial-Mediated Apoptosis in Lymphoma Cells by the Diterpenoid Lactone Andrographolide, the Active Component of Andrographis paniculata , 2010, Clinical Cancer Research.

[18]  M. Kay,et al.  FATP2 is a hepatic fatty acid transporter and peroxisomal very long-chain acyl-CoA synthetase. , 2010, American journal of physiology. Endocrinology and metabolism.

[19]  Theresa A. Storm,et al.  Silencing of Hepatic Fatty Acid Transporter Protein 5 in Vivo Reverses Diet-induced Non-alcoholic Fatty Liver Disease and Improves Hyperglycemia* , 2008, Journal of Biological Chemistry.

[20]  R. Gimeno,et al.  Targeted deletion of FATP5 reveals multiple functions in liver metabolism: alterations in hepatic lipid homeostasis. , 2006, Gastroenterology.

[21]  L. Standish,et al.  A phase I trial of andrographolide in HIV positive patients and normal volunteers , 2000, Phytotherapy research : PTR.

[22]  Anupam Sharma,et al.  Hepatoprotective activity of andrographolide from Andrographis paniculata against carbontetrachloride. , 1990, The Indian journal of medical research.

[23]  B. Staels,et al.  PPARs in obesity-induced T2DM, dyslipidaemia and NAFLD , 2017, Nature Reviews Endocrinology.